David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
PUT
Applied Materials
AMAT
$391B
| $40.8M | 0.05% |
882,400
+452,300
| +105% | +$23.3M |
|
|
ENDP
427
DELISTED
Endo International plc
ENDP
| $40.7M | 0.05% |
4,318,896
+833,495
| +24% | +$5.6M |
|
428
United Therapeutics
UTHR
$22B
| $40.7M | 0.05% |
359,920
-52,272
| -13% | -$5.75M |
|
|
FNGN
429
DELISTED
Financial Engines, Inc.
FNGN
| $40.7M | 0.05% |
907,007
-304,641
| -25% | -$12.6M |
|
430
Bloomin' Brands
BLMN
$996M
| $40.4M | 0.05% |
2,009,329
+828,664
| +70% | +$18.8M |
|
431
LiveRamp
RAMP
$2.28B
| $40.2M | 0.05% |
1,341,289
+292,512
| +28% | +$8.01M |
|
432
Zimmer Biomet
ZBH
$19.3B
| $40.1M | 0.05% |
370,884
+61,065
| +20% | +$6.65M |
|
433
Melco Resorts & Entertainment
MLCO
$2.09B
| $40.1M | 0.05% |
1,432,961
+708,762
| +98% | +$21.7M |
|
434
Trane Technologies
TT
$99.8B
| $40.1M | 0.05% |
446,600
-137,521
| -24% | -$12.1M |
|
435
Williams Companies
WMB
$86.2B
| $39.8M | 0.05% |
1,468,315
-427,076
| -23% | -$11.3M |
|
436
Pediatrix Medical
MD
$2.16B
| $39.5M | 0.05% |
913,672
+595,958
| +188% | +$28.6M |
|
|
437
PUT
Bristol-Myers Squibb
BMY
$137B
| $39.4M | 0.05% |
712,600
+322,600
| +83% | +$17.4M |
|
438
Cenovus Energy
CVE
$60.7B
| $39.4M | 0.05% |
+3,795,054
| New | +$38.2M |
|
|
EQC
439
DELISTED
Equity Commonwealth
EQC
| $39.4M | 0.05% |
1,249,584
-250,004
| -17% | -$7.73M |
|
|
PRSP
440
DELISTED
Perspecta Inc. Common Stock
PRSP
| $39.3M | 0.05% |
+1,914,792
| New | +$42.9M |
|
441
NCR Voyix
VYX
$1.09B
| $38.7M | 0.05% |
2,106,120
-20,391
| -1% | -$385K |
|
|
CMA
442
DELISTED
Comerica
CMA
| $38.2M | 0.05% |
419,998
-85,699
| -17% | -$8.21M |
|
443
Ares Capital
ARCC
$14.3B
| $37.8M | 0.05% |
2,300,241
+1,079,252
| +88% | +$17.7M |
|
444
Jacobs Solutions
J
$17.6B
| $37.7M | 0.05% |
717,046
-232,043
| -24% | -$11.9M |
|
445
Lockheed Martin
LMT
$130B
| $37.7M | 0.05% |
127,466
-33,652
| -21% | -$10.9M |
|
446
Equifax
EFX
$22.6B
| $37.4M | 0.05% |
298,625
-761,953
| -72% | -$90.3M |
|
|
ZEN
447
DELISTED
ZENDESK INC
ZEN
| $37.3M | 0.05% |
683,799
+478,219
| +233% | +$25.4M |
|
|
MDRX
448
DELISTED
Veradigm Inc. Common Stock
MDRX
| $37.1M | 0.05% |
3,091,113
+39,366
| +1% | +$485K |
|
449
Zebra Technologies
ZBRA
$17.4B
| $37.1M | 0.05% |
258,718
-27,720
| -10% | -$4.08M |
|
450
MGM Resorts International
MGM
$11B
| $37M | 0.05% |
1,275,732
-1,345,175
| -51% | -$43.4M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.